Innoviva (INVA) Financials

$21.00 -0.46 (-2.14%)

Closing price 06/20/2025 04:00 PM Eastern

Extended Trading

$20.99 -0.01 (-0.05%)

As of 06/20/2025 06:04 PM Eastern

Annual Income Statements for Innoviva

This table shows Innoviva's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	-168	-19	119	134	395	157	224	266	214	180	23
Consolidated Net Income / (Loss)	-168	-19	119	134	406	191	294	369	220	180	23
Net Income / (Loss) Continuing Operations	-74	-19	60	134	406	191	294	369	220	180	23
Total Pre-Tax Income	-74	-19	60	134	210	233	354	445	287	194	37
Total Operating Income	-34	32	109	184	238	246	371	466	320	202	43
Total Gross Profit	8.43	54	134	217	261	261	337	392	318	268	322
Total Revenue	8.43	54	134	217	261	261	337	392	331	310	359
Operating Revenue	8.43	54	134	217	261	261	337	392	331	310	359
Total Cost of Revenue	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	14	43	37
Operating Cost of Revenue	-	-	-	-	-	-	0.00	0.00	14	43	37
Total Operating Expenses	42	22	25	34	23	15	-35	-74	-2.86	65	279
Selling, General & Admin Expense	35	20	23	32	23	15	14	16	64	98	116
Research & Development Expense	7.50	2.62	1.39	1.36	0.00	0.00	1.79	0.58	41	34	14
Amortization Expense	-	-	-	-	-	-	0.00	0.00	5.58	22	26
Other Operating Expenses / (Income)	-	-	-	-	-	-	-50	-91	-113	-89	123
Total Other Income / (Expense), net	-40	-50	-49	-49	-28	-13	-17	-21	-33	-8.31	-6.07
Interest Expense	37	52	52	44	24	19	18	19	36	19	22
Interest & Investment Income	0.56	0.34	0.58	1.31	1.66	5.54	1.52	1.84	6.37	16	19
Other Income / (Expense), net	-3.27	1.12	2.48	-7.04	-5.70	-0.35	-0.35	-3.63	-3.37	-4.97	-3.00
Income Tax Expense	-	-	0.10	0.00	-196	42	60	76	67	14	14
Net Income / (Loss) Attributable to Noncontrolling Interest	-	0.00	0.00	0.13	11	34	69	103	6.34	0.00	0.00
Basic Earnings per Share	($1.50)	($0.16)	$0.54	$1.25	$3.92	$1.55	$2.21	$3.24	$3.07	$2.75	$0.37
Weighted Average Basic Shares Outstanding	112.06M	115.37M	110.28M	106.95M	100.85M	101.15M	101.32M	82.06M	69.64M	65.44M	62.73M
Diluted Earnings per Share	($1.50)	($0.16)	$0.53	$1.17	$3.53	$1.43	$2.02	$2.87	$2.37	$2.20	$0.36
Weighted Average Diluted Shares Outstanding	112.06M	115.37M	123.23M	119.87M	113.41M	113.41M	113.55M	94.31M	95.25M	86.88M	74.19M
Weighted Average Basic & Diluted Shares Outstanding	112.06M	117.30M	110.30M	107.30M	101.12M	101.30M	101.39M	69.57M	68.13M	63.23M	62.68M

This table shows Innoviva's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Net Income / (Loss) Attributable to Common Shareholders	266	-68	35	1.28	82	62	37	-35	1.21	20	-47
Consolidated Net Income / (Loss)	229	-68	35	1.28	82	62	37	-35	1.21	20	-47
Net Income / (Loss) Continuing Operations	229	-68	35	1.28	82	62	37	-35	1.21	20	-47
Total Pre-Tax Income	286	-65	41	5.81	86	61	45	-39	6.85	25	-39
Total Operating Income	289	-41	44	8.53	87	63	26	-36	8.07	24	41
Total Gross Profit	64	56	66	72	57	73	60	91	80	85	73
Total Revenue	67	66	76	81	67	86	77	100	90	92	89
Operating Revenue	67	66	76	81	67	86	77	100	90	92	89
Total Cost of Revenue	3.68	10	10	8.98	10	13	17	8.47	9.99	7.17	15
Operating Cost of Revenue	3.68	10	10	8.98	10	13	17	8.47	9.99	7.17	15
Total Operating Expenses	-226	96	22	63	-30	9.66	34	127	71	61	32
Selling, General & Admin Expense	28	17	20	24	29	26	30	28	26	31	27
Research & Development Expense	12	9.99	13	15	3.99	2.36	3.88	2.56	3.55	3.67	4.40
Total Other Income / (Expense), net	-2.93	-24	-2.41	-2.73	-1.33	-1.85	19	-3.30	-1.22	1.15	-80
Interest Expense	5.10	25	4.43	4.38	4.40	5.95	5.85	5.80	5.81	4.75	4.71
Interest & Investment Income	2.14	3.19	3.37	3.55	4.11	4.79	40	3.47	5.50	5.77	-9.01
Other Income / (Expense), net	0.03	-2.62	-1.35	-1.90	-1.05	-0.68	-15	-0.97	-0.91	0.13	-66
Income Tax Expense	57	3.63	6.28	4.53	3.91	-0.33	8.59	-4.59	5.64	4.36	8.00
Basic Earnings per Share	$3.81	($0.98)	$0.51	$0.02	$1.26	$0.96	$0.58	($0.55)	$0.02	$0.32	($0.74)
Weighted Average Basic Shares Outstanding	69.73M	69.64M	67.79M	65.34M	64.95M	65.44M	63.19M	62.53M	62.57M	62.73M	62.71M
Diluted Earnings per Share	$2.80	($0.68)	$0.42	$0.02	$0.98	$0.78	$0.46	($0.55)	$0.02	$0.43	($0.74)
Weighted Average Diluted Shares Outstanding	95.83M	95.25M	89.79M	65.49M	86.16M	86.88M	84.53M	62.53M	62.95M	74.19M	62.71M
Weighted Average Basic & Diluted Shares Outstanding	69.78M	68.13M	65.50M	65.10M	64.09M	63.23M	62.44M	62.56M	62.60M	62.68M	62.78M

This table details how cash moves in and out of Innoviva's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	-47	62	-41	-45	-11	216	-32	-45	90	-98	111
Net Cash From Operating Activities	-131	10	61	142	224	257	313	364	202	141	189
Net Cash From Continuing Operating Activities	-131	10	61	142	224	257	313	364	202	141	189
Net Income / (Loss) Continuing Operations	-168	-19	60	134	406	191	294	369	220	180	23
Consolidated Net Income / (Loss)	-168	-19	60	134	406	191	294	369	220	180	23
Depreciation Expense	12	14	14	14	14	14	14	14	14	14	14
Amortization Expense	4.15	3.53	2.65	4.69	7.17	5.25	7.92	9.14	7.64	24	28
Non-Cash Adjustments To Reconcile Net Income	52	28	6.81	17	8.98	2.38	-49	-88	-72	-56	143
Changes in Operating Assets and Liabilities, net	-30	-17	-22	-28	-213	45	46	60	32	-20	-20
Net Cash From Investing Activities	-65	159	-4.58	-23	3.52	-18	-315	44	-57	-67	-64
Net Cash From Continuing Investing Activities	-65	159	-4.58	-23	3.52	-18	-315	44	-57	-67	-64
Purchase of Property, Plant & Equipment	-0.69	-0.01	-0.28	0.00	0.00	-0.01	-0.01	0.00	-0.07	-0.41	-0.27
Acquisitions	-	-	-	-	-	-	0.00	-44	-204	0.00	-4.00
Purchase of Investments	-277	-87	-96	-68	-72	-232	-401	66	-98	-139	-135
Sale of Property, Plant & Equipment	0.14	-	-	-	-	-	-	-	0.00	0.00	0.10
Divestitures	-	-	-	-	-	-	0.00	0.00	23	0.00	0.00
Sale and/or Maturity of Investments	347	246	91	44	75	214	86	21	24	73	76
Other Investing Activities, net	-134	-	-	-	-	0.00	0.00	0.00	198	0.00	0.00
Net Cash From Financing Activities	149	-107	-98	-163	-238	-24	-30	-452	-56	-172	-13
Net Cash From Continuing Financing Activities	149	-107	-98	-163	-238	-24	-30	-452	-56	-172	-13
Repayment of Debt	0.00	0.00	-6.83	-506	-230	-14	0.00	0.00	-165	-96	0.00
Repurchase of Common Equity	0.00	-26	-78	-98	-	0.00	0.00	-394	-8.50	-76	-15
Payment of Dividends	-335	-87	-0.96	-0.26	-6.04	-11	-30	-59	-70	0.00	0.00
Issuance of Debt	435	0.00	0.00	443	-	-	0.00	0.00	253	0.00	0.00
Issuance of Common Equity	55	8.24	0.39	0.44	1.14	0.63	0.44	1.17	0.37	0.17	1.47
Other Financing Activities, net	-5.66	-2.19	-0.50	-2.13	-3.07	-0.09	0.25	-0.06	-65	-0.08	-0.14
Cash Interest Paid	9.21	26	49	40	18	11	9.93	9.93	12	11	10
Cash Income Taxes Paid	-	-	-	-	-	-	0.00	0.00	54	0.00	12

This table details how cash moves in and out of Innoviva's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Net Change in Cash & Equivalents	17	-9.78	-147	29	6.97	14	-15	39	44	44	14
Net Cash From Operating Activities	16	8.90	26	38	44	33	37	44	49	59	49
Net Cash From Continuing Operating Activities	16	8.90	26	38	44	33	37	43	49	59	49
Net Income / (Loss) Continuing Operations	229	-68	35	1.28	82	62	37	-35	1.21	20	-47
Consolidated Net Income / (Loss)	229	-68	35	1.28	82	62	37	-35	1.21	20	-47
Depreciation Expense	3.36	3.48	3.48	3.48	3.48	3.48	3.51	3.48	3.48	3.49	3.49
Amortization Expense	2.07	4.63	4.33	5.47	7.03	7.03	6.97	6.96	7.04	7.04	7.02
Non-Cash Adjustments To Reconcile Net Income	-261	97	-8.76	32	-64	-15	-15	98	38	23	82
Changes in Operating Assets and Liabilities, net	42	-28	-8.23	-3.59	16	-24	5.26	-30	-0.36	5.80	2.66
Net Cash From Investing Activities	98	-8.68	-36	-	-26	-5.15	-43	-	-5.27	-15	-35
Net Cash From Continuing Investing Activities	98	-8.68	-36	-	-26	-5.15	-43	-	-5.27	-15	-35
Purchase of Investments	-55	8.67	-37	-1.19	-63	-38	-48	-0.63	-52	-34	-55
Sale of Property, Plant & Equipment	-	-	0.00	-	-	-	0.10	-	-	0.00	0.00
Sale and/or Maturity of Investments	55	41	1.29	1.19	37	33	5.34	0.63	47	23	20
Net Cash From Financing Activities	-96	-10	-137	-9.21	-11	-15	-9.17	-5.07	0.21	0.57	0.18
Net Cash From Continuing Financing Activities	-96	-10	-137	-9.21	-11	-15	-9.17	-5.07	0.21	0.57	0.18
Repurchase of Common Equity	-	-8.50	-41	-9.29	-11	-15	-9.57	-5.21	-	-	0.00
Issuance of Common Equity	0.00	0.03	0.00	0.11	-	0.06	0.49	0.16	0.23	0.59	0.25
Other Financing Activities, net	-42	-1.53	-0.02	-0.03	-0.01	-0.01	-0.08	-0.02	-0.02	-0.02	-0.07
Cash Interest Paid	6.33	-	6.20	-	5.18	-	5.18	-	5.18	-	5.18

This table presents Innoviva's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Total Assets	522	409	379	367	548	725	1,000	926	1,231	1,244	1,301
Total Current Assets	252	214	198	200	199	431	342	314	444	344	554
Cash & Equivalents	97	159	118	73	62	278	246	202	291	194	305
Short-Term Investments	144	28	32	56	52	73	-	-	-	0.00	108
Note & Lease Receivable	-	-	-	-	-	-	-	111	55	70	66
Accounts Receivable	-	26	47	71	83	79	94	0.00	9.40	14	20
Inventories, net	-	-	-	-	-	-	-	0.00	56	41	34
Prepaid Expenses	1.13	0.81	0.77	0.75	0.85	0.96	1.64	1.37	30	22	21
Other Current Assets	11	-	-	-	-	-	-	0.07	2.93	4.26	0.66
Plant, Property, & Equipment, net	0.32	0.22	0.37	0.21	0.16	0.03	0.03	0.01	0.17	0.48	0.51
Total Noncurrent Assets	269	194	181	167	349	294	657	613	788	899	746
Long-Term Investments	43	-	-	-	-	0.00	438	484	403	561	394
Goodwill	-	-	-	-	-	-	-	0.00	27	18	18
Intangible Assets	-	-	-	-	-	-	-	0.00	253	230	208
Noncurrent Deferred & Refundable Income Taxes	-	-	-	0.00	196	154	94	17	-	0.00	12
Other Noncurrent Operating Assets	226	194	181	167	153	139	125	112	105	90	114
Total Liabilities & Shareholders' Equity	522	409	379	367	548	725	1,000	926	1,231	1,244	1,301
Total Liabilities	745	752	732	610	389	383	392	400	666	569	610
Total Current Liabilities	14	13	20	35	5.70	5.37	6.11	5.81	135	38	236
Short-Term Debt	-	0.00	7.75	25	-	-	-	0.00	96	0.00	192
Accounts Payable	1.06	0.82	0.13	0.60	0.01	0.01	0.07	0.03	2.94	6.72	2.13
Accrued Expenses	-	-	-	-	-	-	-	-	-	20	30
Current Deferred Revenue	1.08	0.89	0.89	-	-	-	-	0.00	2.09	1.28	1.13
Current Deferred & Payable Income Tax Liabilities	-	-	-	-	-	-	-	0.00	0.15	-	0.00
Current Employee Benefit Liabilities	1.96	1.66	2.36	1.72	0.47	0.65	0.49	0.62	8.02	7.02	7.38
Other Current Nonoperating Liabilities	7.55	7.91	7.83	5.92	4.26	4.15	4.15	4.15	4.36	3.42	3.42
Total Noncurrent Liabilities	731	738	712	575	383	377	386	395	531	530	374
Long-Term Debt	726	733	708	574	383	377	386	395	444	446	256
Noncurrent Deferred Revenue	3.79	3.10	2.21	-	-	-	-	-	-	12	53
Other Noncurrent Operating Liabilities	1.82	1.86	1.38	0.94	0.59	0.22	0.11	0.00	81	72	64
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	-223	-343	-353	-243	159	342	608	526	566	675	691
Total Preferred & Common Equity	-223	-343	-353	-243	154	313	540	415	566	675	691
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	-223	-343	-353	-243	154	313	540	415	566	675	691
Common Stock	1,454	1,353	1,283	1,259	1,257	1,260	1,262	1,265	1,165	1,094	693
Retained Earnings	-1,674	-1,692	-1,633	-1,499	-1,104	-946	-722	-456	-205	-25	-1.80
Treasury Stock	-3.26	-	-	-	-	-	-	-	-394	-394	0.00

This table presents Innoviva's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q2 2022	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025
Period end date	6/30/2022	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025
Total Assets	1,138	1,328	1,130	1,118	1,188	1,268	1,225	1,232	1,254
Total Current Assets	400	455	296	324	305	311	358	401	582
Cash & Equivalents	284	301	144	173	180	178	217	261	319
Short-Term Investments	-	0.28	-	-	-	-	-	-	128
Note & Lease Receivable	-	-	60	66	57	62	67	61	61
Accounts Receivable	112	72	15	15	11	14	27	31	17
Inventories, net	-	71	50	47	41	37	37	34	41
Prepaid Expenses	3.95	7.93	24	21	15	17	8.48	13	15
Other Current Assets	1.12	2.43	2.82	2.14	1.99	2.99	2.15	2.05	0.31
Plant, Property, & Equipment, net	0.18	0.17	0.18	0.16	0.36	0.32	0.43	0.54	0.48
Total Noncurrent Assets	737	873	833	795	883	956	866	830	672
Long-Term Investments	494	489	456	398	422	628	536	508	330
Goodwill	5.54	16	28	15	18	18	18	18	18
Intangible Assets	105	258	248	243	237	224	217	211	202
Noncurrent Deferred & Refundable Income Taxes	23	0.00	-	6.33	4.95	-	11	15	12
Other Noncurrent Operating Assets	109	109	101	132	201	86	83	79	110
Total Liabilities & Shareholders' Equity	1,138	1,328	1,130	1,118	1,188	1,268	1,225	1,232	1,254
Total Liabilities	572	686	568	563	561	564	559	563	607
Total Current Liabilities	126	164	38	39	36	30	28	224	235
Short-Term Debt	96	96	0.00	0.00	0.00	-	-	192	192
Accounts Payable	4.32	3.81	5.93	4.59	3.78	0.89	2.04	4.17	4.70
Accrued Expenses	-	-	-	-	-	-	-	18	31
Current Deferred Revenue	-	2.85	2.09	3.25	1.55	0.99	0.86	0.72	1.00
Current Deferred & Payable Income Tax Liabilities	-	34	0.15	0.15	0.15	-	-	2.62	1.54
Current Employee Benefit Liabilities	3.87	6.47	4.22	5.47	5.17	3.42	4.76	5.97	3.79
Other Current Nonoperating Liabilities	4.50	5.70	0.83	3.42	0.83	0.83	3.42	0.83	0.83
Total Noncurrent Liabilities	446	522	530	524	524	534	531	339	373
Long-Term Debt	443	444	445	445	446	447	447	256	257
Noncurrent Deferred Revenue	-	-	-	-	-	-	-	12	54
Other Noncurrent Operating Liabilities	3.09	78	70	69	79	72	72	71	62
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	565	641	561	555	627	704	666	669	647
Total Preferred & Common Equity	388	641	0.00	555	627	704	666	669	647
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	388	641	561	555	627	704	666	669	647
Common Stock	1,184	1,172	1,125	1,118	1,108	1,086	689	691	695
Retained Earnings	-402	-137	-170	-169	-87	11	-23	-22	-48
Other Equity Adjustments	-394	-	-	-	-	-	-	-	0.00

This table displays calculated financial ratios and metrics derived from Innoviva's official financial filings.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	86.08%	539.74%	147.58%	62.63%	20.16%	0.00%	29.03%	16.35%	-15.45%	-6.30%	15.54%
EBITDA Growth	-50.62%	340.27%	155.32%	52.45%	29.89%	4.55%	48.16%	23.59%	-30.25%	-30.54%	-64.96%
EBIT Growth	-68.61%	187.90%	240.87%	58.40%	31.71%	5.79%	50.82%	24.65%	-31.45%	-37.72%	-79.51%
NOPAT Growth	17.52%	193.08%	392.24%	68.73%	150.78%	-56.12%	52.47%	25.34%	-36.30%	-23.80%	-85.49%
Net Income Growth	1.31%	88.86%	734.71%	12.77%	202.62%	-53.00%	53.84%	25.53%	-40.28%	-18.41%	-86.98%
EPS Growth	10.18%	89.33%	431.25%	120.75%	201.71%	-59.49%	41.26%	42.08%	-17.42%	-7.17%	-83.64%
Operating Cash Flow Growth	-0.87%	107.75%	501.95%	132.44%	57.69%	15.18%	21.62%	16.19%	-44.55%	-30.07%	33.76%
Free Cash Flow Firm Growth	-63.36%	120.57%	165.32%	71.57%	53.97%	-0.73%	41.06%	24.92%	-85.02%	239.49%	-73.97%
Invested Capital Growth	232.62%	-6.79%	4.44%	5.90%	84.70%	-13.62%	-16.05%	-23.47%	73.98%	-11.13%	-9.09%
Revenue Q/Q Growth	223.85%	40.52%	18.42%	13.54%	4.12%	-1.47%	4.50%	4.59%	-11.22%	6.90%	1.69%
EBITDA Q/Q Growth	-10,338.00%	68.81%	19.64%	17.76%	4.30%	-1.52%	18.62%	14.05%	-40.95%	84.82%	-31.94%
EBIT Q/Q Growth	-156.06%	174.17%	23.35%	18.91%	4.83%	-1.52%	19.76%	14.72%	-42.79%	114.88%	-48.89%
NOPAT Q/Q Growth	-128.29%	119.05%	22.79%	18.56%	102.44%	-52.63%	19.88%	14.63%	-46.04%	159.42%	-62.50%
Net Income Q/Q Growth	16.79%	51.88%	210.36%	-16.48%	107.71%	-52.53%	6.20%	-7.37%	-34.10%	260.33%	-63.78%
EPS Q/Q Growth	18.92%	50.00%	55.88%	31.46%	107.65%	-57.31%	3.06%	-8.01%	-27.74%	197.30%	-49.30%
Operating Cash Flow Q/Q Growth	21.29%	825.72%	30.27%	23.29%	6.64%	2.03%	6.23%	3.74%	-30.73%	20.87%	15.97%
Free Cash Flow Firm Q/Q Growth	9.40%	1,169.56%	2.37%	12.40%	17.12%	-2.91%	20.61%	8.82%	-77.25%	9,040.18%	-68.84%
Invested Capital Q/Q Growth	5.76%	-4.60%	3.63%	8.17%	96.90%	-1.18%	-4.92%	-1.71%	4.98%	-21.51%	-3.55%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	95.84%	86.27%	89.80%
EBITDA Margin	-247.55%	92.97%	95.88%	89.88%	97.16%	101.58%	116.63%	123.89%	102.19%	75.76%	22.98%
Operating Margin	-402.34%	58.54%	81.60%	84.53%	91.28%	94.39%	110.28%	118.95%	96.70%	65.19%	12.11%
EBIT Margin	-441.14%	60.61%	83.45%	81.29%	89.10%	94.25%	110.17%	118.03%	95.68%	63.59%	11.28%
Profit (Net Income) Margin	-1,997.68%	-34.77%	89.15%	61.81%	155.68%	73.17%	87.24%	94.12%	66.48%	57.89%	6.52%
Tax Burden Percent	229.11%	100.00%	199.68%	100.00%	193.25%	82.01%	82.94%	82.83%	76.76%	92.59%	62.57%
Interest Burden Percent	197.66%	-57.37%	53.50%	76.05%	90.41%	94.67%	95.47%	96.27%	90.51%	98.31%	92.42%
Effective Tax Rate	0.00%	0.00%	0.16%	0.00%	-93.25%	17.99%	17.06%	17.17%	23.24%	7.41%	37.43%
Return on Invested Capital (ROIC)	-16.13%	10.10%	50.42%	80.88%	138.53%	50.27%	89.90%	139.86%	75.00%	47.65%	7.70%
ROIC Less NNEP Spread (ROIC-NNEP)	-148.40%	1.96%	52.24%	71.48%	124.07%	42.97%	100.65%	145.80%	86.78%	51.04%	8.85%
Return on Net Nonoperating Assets (RNNOA)	-428.53%	-3.47%	-84.66%	-125.96%	-1,109.96%	25.95%	-28.04%	-74.80%	-34.65%	-18.68%	-4.27%
Return on Equity (ROE)	-444.65%	6.63%	-34.23%	-45.08%	-971.44%	76.22%	61.86%	65.06%	40.35%	28.97%	3.42%
Cash Return on Invested Capital (CROIC)	-123.67%	17.13%	46.07%	75.15%	79.03%	64.88%	107.35%	166.45%	21.00%	59.44%	17.22%
Operating Return on Assets (OROA)	-6.19%	7.03%	28.29%	47.32%	50.80%	38.65%	43.04%	48.03%	29.38%	15.95%	3.18%
Return on Assets (ROA)	-28.01%	-4.03%	30.22%	35.98%	88.76%	30.01%	34.08%	38.30%	20.41%	14.52%	1.84%
Return on Common Equity (ROCE)	-444.65%	6.63%	-34.23%	-45.09%	-1,036.71%	71.03%	55.57%	54.78%	36.24%	28.97%	3.42%
Return on Equity Simple (ROE_SIMPLE)	75.43%	5.48%	-33.73%	-55.29%	264.57%	60.92%	54.42%	88.93%	38.93%	26.63%	3.38%
Net Operating Profit after Tax (NOPAT)	-24	22	109	184	460	202	308	386	246	187	27
NOPAT Margin	-281.64%	40.98%	81.47%	84.52%	176.41%	77.40%	91.46%	98.53%	74.23%	60.37%	7.58%
Net Nonoperating Expense Percent (NNEP)	132.28%	8.14%	-1.82%	9.40%	14.46%	7.30%	-10.75%	-5.94%	-11.78%	-3.39%	-1.15%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	22.23%	16.72%	2.39%
Cost of Revenue to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	4.16%	13.73%	10.20%
SG&A Expenses to Revenue	413.42%	36.61%	17.36%	14.85%	8.72%	5.62%	4.12%	4.13%	19.18%	31.64%	32.25%
R&D to Revenue	88.91%	4.85%	1.04%	0.62%	0.00%	0.00%	0.53%	0.15%	12.50%	10.93%	3.81%
Operating Expenses to Revenue	502.34%	41.46%	18.40%	15.47%	8.72%	5.62%	-10.28%	-18.95%	-0.86%	21.07%	77.68%
Earnings before Interest and Taxes (EBIT)	-37	33	111	177	233	246	371	463	317	197	40
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-21	50	128	195	254	265	393	485	339	235	82
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	0.00	11.48	4.57	2.33	2.89	1.63	1.52	1.57
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	11.48	4.57	2.33	2.89	3.23	2.41	2.34
Price to Revenue (P/Rev)	0.12	0.02	8.71	7.06	6.76	5.49	3.73	3.06	2.79	3.31	3.03
Price to Earnings (P/E)	0.00	0.00	9.77	11.43	4.46	9.12	5.60	4.51	4.32	5.72	46.43
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	10.23%	8.75%	22.41%	10.97%	17.86%	22.18%	23.14%	17.48%	2.15%
Enterprise Value to Invested Capital (EV/IC)	1.96	2.59	7.84	8.58	4.72	4.00	3.28	4.26	1.85	1.94	2.16
Enterprise Value to Revenue (EV/Rev)	52.56	10.14	12.95	9.22	7.80	5.70	3.04	2.60	2.33	2.32	2.03
Enterprise Value to EBITDA (EV/EBITDA)	0.00	10.90	13.50	10.26	8.03	5.62	2.61	2.10	2.28	3.06	8.83
Enterprise Value to EBIT (EV/EBIT)	0.00	16.72	15.51	11.35	8.76	6.05	2.76	2.20	2.43	3.65	18.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	24.74	15.89	10.91	4.42	7.37	3.33	2.64	3.13	3.84	26.78
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	53.98	28.35	14.13	9.11	5.78	3.27	2.80	3.82	5.10	3.86
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	14.59	17.39	11.74	7.75	5.71	2.79	2.22	11.20	3.08	11.97
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	-3.25	-2.14	-2.03	-2.47	2.41	1.10	0.63	0.75	0.96	0.66	0.65
Long-Term Debt to Equity	-3.25	-2.14	-2.01	-2.37	2.41	1.10	0.63	0.75	0.79	0.66	0.37
Financial Leverage	2.89	-1.77	-1.62	-1.76	-8.95	0.60	-0.28	-0.51	-0.40	-0.37	-0.48
Leverage Ratio	15.88	-1.64	-1.13	-1.25	-10.94	2.54	1.82	1.70	1.98	1.99	1.86
Compound Leverage Factor	31.38	0.94	-0.61	-0.95	-9.89	2.40	1.73	1.64	1.79	1.96	1.72
Debt to Total Capital	144.47%	187.75%	197.22%	168.05%	70.65%	52.43%	38.81%	42.87%	48.85%	39.80%	39.35%
Short-Term Debt to Total Capital	0.00%	0.00%	2.13%	7.01%	0.00%	0.00%	0.00%	0.00%	8.70%	0.00%	16.85%
Long-Term Debt to Total Capital	144.47%	187.75%	195.08%	161.04%	70.65%	52.43%	38.81%	42.87%	40.16%	39.80%	22.49%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.04%	1.01%	3.98%	6.84%	12.08%	0.00%	0.00%	0.00%
Common Equity to Total Capital	-44.47%	-87.75%	-97.22%	-68.09%	28.34%	43.59%	54.35%	45.05%	51.15%	60.20%	60.65%
Debt to EBITDA	-34.76	14.62	5.59	3.07	1.51	1.42	0.98	0.81	1.60	1.90	5.44
Net Debt to EBITDA	-21.19	10.88	4.42	2.41	1.06	0.10	-0.76	-0.60	-0.45	-1.31	-4.35
Long-Term Debt to EBITDA	-34.76	14.62	5.53	2.94	1.51	1.42	0.98	0.81	1.31	1.90	3.11
Debt to NOPAT	-30.55	33.16	6.58	3.26	0.83	1.87	1.25	1.02	2.20	2.38	16.49
Net Debt to NOPAT	-18.62	24.69	5.20	2.56	0.58	0.13	-0.97	-0.75	-0.62	-1.64	-13.17
Long-Term Debt to NOPAT	-30.55	33.16	6.51	3.13	0.83	1.87	1.25	1.02	1.81	2.38	9.43
Altman Z-Score	-4.16	-4.81	-3.19	-1.49	2.20	2.61	2.88	3.58	2.02	2.13	1.74
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	-0.03%	-6.72%	6.80%	10.16%	15.80%	10.19%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	18.33	15.89	9.88	5.77	34.92	80.29	55.98	54.02	3.29	9.03	2.35
Quick Ratio	17.48	15.83	9.84	5.75	34.77	80.11	55.71	53.77	2.63	7.28	2.11
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-182	37	99	171	263	261	368	460	69	234	61
Operating Cash Flow to CapEx	-23,811.11%	144,728.57%	21,936.69%	0.00%	0.00%	2,145,483.33%	2,408,561.54%	0.00%	301,083.58%	34,322.14%	111,650.89%
Free Cash Flow to Firm to Interest Expense	-4.94	0.72	1.90	3.91	10.97	13.97	20.07	24.10	1.89	12.20	2.74
Operating Cash Flow to Interest Expense	-3.54	0.20	1.16	3.25	9.33	13.80	17.08	19.08	5.53	7.36	8.50
Operating Cash Flow Less CapEx to Interest Expense	-3.56	0.20	1.16	3.25	9.33	13.80	17.08	19.08	5.53	7.34	8.49
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.01	0.12	0.34	0.58	0.57	0.41	0.39	0.41	0.31	0.25	0.28
Accounts Receivable Turnover	0.00	0.00	3.66	3.70	3.39	3.21	3.89	0.00	0.00	26.03	20.59
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.88	0.98
Fixed Asset Turnover	1.60	197.98	453.55	752.92	1,414.66	2,704.83	11,042.43	19,593.30	3,641.09	950.88	719.58
Accounts Payable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	9.30	8.83	8.27
Days Sales Outstanding (DSO)	0.00	0.00	99.84	98.63	107.56	113.77	93.94	0.00	0.00	14.02	17.73
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	413.60	371.31
Days Payable Outstanding (DPO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	39.24	41.33	44.13
Cash Conversion Cycle (CCC)	0.00	0.00	99.84	98.63	107.56	113.77	93.94	0.00	-39.24	386.29	344.92
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	226	211	220	234	431	373	313	239	416	370	336
Invested Capital Turnover	0.06	0.25	0.62	0.96	0.79	0.65	0.98	1.42	1.01	0.79	1.02
Increase / (Decrease) in Invested Capital	158	-15	9.38	13	198	-59	-60	-73	177	-46	-34
Enterprise Value (EV)	443	547	1,729	2,003	2,037	1,489	1,025	1,019	771	720	728
Market Capitalization	0.98	1.00	1,163	1,533	1,763	1,434	1,256	1,199	925	1,028	1,086
Book Value per Share	($1.94)	($2.92)	($3.25)	($2.25)	$1.52	$3.10	$5.33	$5.97	$8.11	$10.53	$11.04
Tangible Book Value per Share	($1.94)	($2.92)	($3.25)	($2.25)	$1.52	$3.10	$5.33	$5.97	$4.10	$6.66	$7.43
Total Capital	502	390	363	357	542	719	993	921	1,106	1,121	1,140
Total Debt	726	733	716	599	383	377	386	395	540	446	448
Total Long-Term Debt	726	733	708	574	383	377	386	395	444	446	256
Net Debt	442	546	566	470	268	26	-299	-291	-154	-308	-358
Capital Expenditures (CapEx)	0.55	0.01	0.28	0.00	0.00	0.01	0.01	0.00	0.07	0.41	0.17
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-2.07	14	35	62	78	75	89	106	114	113	98
Debt-free Net Working Capital (DFNWC)	238	201	186	191	193	426	336	308	405	306	510
Net Working Capital (NWC)	238	201	178	166	193	426	336	308	309	306	318
Net Nonoperating Expense (NNE)	145	41	-10	49	54	11	14	17	26	7.69	3.79
Net Nonoperating Obligations (NNO)	450	554	573	476	272	30	-295	-287	-149	-305	-355
Total Depreciation and Amortization (D&A)	16	17	17	19	21	19	22	23	22	38	42
Debt-free, Cash-free Net Working Capital to Revenue	-24.57%	25.12%	26.44%	28.34%	30.05%	28.74%	26.56%	27.14%	34.31%	36.26%	27.25%
Debt-free Net Working Capital to Revenue	2,827.30%	372.27%	139.07%	87.76%	74.08%	163.16%	99.75%	78.56%	122.15%	98.59%	142.25%
Net Working Capital to Revenue	2,827.30%	372.27%	133.26%	76.25%	74.08%	163.16%	99.75%	78.56%	93.12%	98.59%	88.71%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($1.50)	($0.16)	$0.54	$1.25	$3.92	$1.55	$2.21	$0.00	$3.07	$0.00	$0.37
Adjusted Weighted Average Basic Shares Outstanding	116.62M	114.12M	110.28M	106.95M	100.85M	101.15M	101.32M	0.00	69.64M	0.00	62.73M
Adjusted Diluted Earnings per Share	($1.50)	($0.16)	$0.53	$1.17	$3.53	$1.43	$2.02	$0.00	$2.37	$0.00	$0.36
Adjusted Weighted Average Diluted Shares Outstanding	116.62M	114.12M	123.23M	119.87M	113.41M	113.41M	113.55M	0.00	95.25M	0.00	74.19M
Adjusted Basic & Diluted Earnings per Share	($1.50)	($0.16)	$0.00	$1.25	$3.92	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	112.06M	115.37M	109.20M	101.82M	101.12M	101.30M	101.39M	0.00	68.13M	0.00	62.68M
Normalized Net Operating Profit after Tax (NOPAT)	-24	22	109	184	167	202	308	386	246	187	27
Normalized NOPAT Margin	-281.64%	40.98%	81.47%	84.52%	63.90%	77.40%	91.46%	98.53%	74.23%	60.37%	7.58%
Pre Tax Income Margin	-871.93%	-34.77%	44.64%	61.82%	80.56%	89.23%	105.18%	113.63%	86.60%	62.52%	10.42%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-1.01	0.63	2.13	4.05	9.71	13.18	20.24	24.25	8.70	10.31	1.82
NOPAT to Interest Expense	-0.64	0.43	2.08	4.21	19.22	10.83	16.80	20.25	6.75	9.78	1.22
EBIT Less CapEx to Interest Expense	-1.02	0.63	2.12	4.05	9.71	13.18	20.24	24.25	8.70	10.28	1.81
NOPAT Less CapEx to Interest Expense	-0.66	0.43	2.07	4.21	19.22	10.83	16.80	20.25	6.75	9.76	1.22
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-198.58%	-465.52%	0.81%	0.19%	1.49%	5.53%	10.37%	16.12%	31.69%	0.00%	0.00%
Augmented Payout Ratio	-198.58%	-602.17%	66.39%	72.81%	1.49%	5.53%	10.37%	122.98%	35.55%	42.14%	63.17%

This table displays calculated financial ratios and metrics derived from Innoviva's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-31.27%	-38.89%	-15.20%	-25.16%	0.00%	30.45%	1.48%	23.34%	33.08%	6.95%	14.37%
EBITDA Growth	195.80%	-117.55%	-2.49%	-43.51%	-67.18%	307.82%	-56.59%	-270.21%	-81.73%	-53.07%	-166.16%
EBIT Growth	208.18%	-122.26%	-10.98%	-71.68%	-70.20%	244.41%	-73.38%	-656.99%	-91.70%	-62.04%	-321.35%
NOPAT Growth	194.06%	-117.97%	-8.53%	-92.47%	-64.04%	323.24%	-43.39%	-1,438.99%	-98.28%	-69.41%	38.81%
Net Income Growth	123.43%	-249.65%	-7.91%	-94.01%	-64.23%	190.07%	4.78%	-2,809.77%	-98.52%	-66.96%	-227.52%
EPS Growth	211.11%	-395.65%	110.00%	-60.00%	-65.00%	214.71%	9.52%	-2,850.00%	-97.96%	-44.87%	-260.87%
Operating Cash Flow Growth	-83.78%	-90.95%	-73.82%	-51.69%	180.06%	273.70%	44.24%	14.50%	10.80%	78.13%	31.23%
Free Cash Flow Firm Growth	-52.17%	-188.79%	-465.12%	-178.93%	-89.23%	153.40%	313.73%	145.08%	1,368.00%	-51.66%	-35.85%
Invested Capital Growth	62.89%	73.98%	22.95%	30.53%	18.87%	-11.13%	-15.38%	-16.17%	-26.02%	-9.09%	-7.14%
Revenue Q/Q Growth	-37.85%	-2.16%	16.06%	6.05%	-16.96%	27.63%	-9.72%	28.90%	-10.40%	2.57%	-3.46%
EBITDA Q/Q Growth	969.28%	-111.90%	242.61%	-68.85%	521.12%	-24.67%	-70.21%	-146.47%	166.69%	93.44%	-142.00%
EBIT Q/Q Growth	1,135.32%	-114.92%	197.72%	-84.28%	1,199.88%	-27.68%	-81.99%	-179.33%	119.37%	230.84%	-205.03%
NOPAT Q/Q Growth	827.60%	-112.25%	229.98%	-94.90%	4,329.60%	-23.92%	-67.04%	-165.06%	105.68%	1,256.61%	49.57%
Net Income Q/Q Growth	973.17%	-129.79%	151.04%	-96.33%	6,309.84%	-25.00%	-40.63%	-194.94%	103.50%	1,576.17%	-329.12%
EPS Q/Q Growth	5,500.00%	-124.29%	161.76%	-95.24%	4,800.00%	-20.41%	-41.03%	-219.57%	103.64%	2,050.00%	-272.09%
Operating Cash Flow Q/Q Growth	-80.15%	-43.28%	188.62%	48.66%	15.09%	-24.32%	11.40%	18.01%	11.36%	21.68%	-17.93%
Free Cash Flow Firm Q/Q Growth	320.53%	-361.65%	80.98%	-154.20%	108.51%	1,197.51%	-23.89%	-55.81%	177.23%	-57.28%	1.02%
Invested Capital Q/Q Growth	19.66%	4.98%	-2.25%	6.30%	8.97%	-21.51%	-6.93%	5.31%	-3.84%	-3.55%	-4.93%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	94.53%	84.63%	86.45%	88.91%	84.86%	84.70%	77.53%	91.52%	88.84%	92.20%	82.72%
EBITDA Margin	438.34%	-53.29%	65.48%	19.23%	143.84%	84.90%	28.01%	-26.54%	19.75%	37.25%	-16.21%
Operating Margin	430.23%	-61.64%	57.02%	10.53%	129.77%	73.45%	33.30%	-36.01%	9.02%	25.65%	46.74%
EBIT Margin	430.27%	-65.63%	55.26%	8.19%	128.21%	72.65%	14.50%	-36.99%	7.99%	25.79%	-28.06%
Profit (Net Income) Margin	341.00%	-103.82%	45.65%	1.58%	121.99%	71.68%	47.14%	-34.72%	1.36%	22.15%	-52.56%
Tax Burden Percent	80.07%	105.61%	84.75%	22.05%	95.46%	100.54%	80.96%	88.30%	17.71%	82.34%	120.72%
Interest Burden Percent	98.98%	149.79%	97.48%	87.50%	99.67%	98.13%	401.67%	106.30%	95.71%	104.30%	155.18%
Effective Tax Rate	19.93%	0.00%	15.25%	77.95%	4.54%	-0.54%	19.04%	0.00%	82.29%	17.66%	0.00%
Return on Invested Capital (ROIC)	401.63%	-43.60%	41.59%	1.76%	82.87%	58.29%	22.35%	-20.95%	1.37%	21.44%	36.43%
ROIC Less NNEP Spread (ROIC-NNEP)	402.59%	-25.28%	42.67%	2.10%	83.50%	59.11%	16.26%	-16.48%	1.46%	21.16%	58.46%
Return on Net Nonoperating Assets (RNNOA)	-175.13%	10.10%	-14.39%	-0.67%	-26.36%	-21.64%	-6.60%	5.74%	-0.54%	-10.21%	-29.70%
Return on Equity (ROE)	226.51%	-33.51%	27.20%	1.10%	56.51%	36.66%	15.75%	-15.21%	0.84%	11.23%	6.73%
Cash Return on Invested Capital (CROIC)	94.53%	21.00%	45.12%	31.29%	-0.60%	59.44%	61.66%	56.34%	47.59%	17.22%	19.85%
Operating Return on Assets (OROA)	145.00%	-20.15%	15.69%	2.11%	29.60%	18.23%	3.77%	-10.43%	2.33%	7.27%	-8.23%
Return on Assets (ROA)	114.92%	-31.88%	12.96%	0.41%	28.16%	17.98%	12.25%	-9.79%	0.40%	6.24%	-15.42%
Return on Common Equity (ROCE)	208.72%	-30.09%	23.16%	0.92%	56.51%	36.66%	15.75%	-15.21%	0.84%	11.23%	6.73%
Return on Equity Simple (ROE_SIMPLE)	52.11%	0.00%	0.00%	35.52%	7.95%	0.00%	25.78%	21.85%	9.66%	0.00%	-9.23%
Net Operating Profit after Tax (NOPAT)	232	-28	37	1.88	83	63	21	-25	1.43	19	29
NOPAT Margin	344.49%	-43.15%	48.32%	2.32%	123.87%	73.84%	26.96%	-25.21%	1.60%	21.12%	32.72%
Net Nonoperating Expense Percent (NNEP)	-0.95%	-18.32%	-1.09%	-0.34%	-0.63%	-0.82%	6.09%	-4.47%	-0.09%	0.29%	-22.03%
Return On Investment Capital (ROIC_SIMPLE)	-	-2.57%	-	-	-	5.65%	1.82%	-	-	1.70%	2.65%
Cost of Revenue to Revenue	5.47%	15.37%	13.55%	11.09%	15.14%	15.30%	22.47%	8.48%	11.16%	7.80%	17.28%
SG&A Expenses to Revenue	41.35%	26.52%	25.84%	29.07%	42.58%	30.66%	39.23%	27.77%	29.29%	34.12%	31.02%
R&D to Revenue	17.43%	15.17%	16.48%	18.51%	5.93%	2.74%	5.00%	2.56%	3.97%	3.99%	4.96%
Operating Expenses to Revenue	-335.70%	146.27%	29.43%	78.38%	-44.91%	11.26%	44.24%	127.53%	79.82%	66.54%	35.98%
Earnings before Interest and Taxes (EBIT)	289	-43	42	6.63	86	62	11	-37	7.16	24	-25
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	295	-35	50	16	97	73	22	-27	18	34	-14
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.26	1.63	1.37	1.50	1.35	1.52	1.37	1.54	1.81	1.57	1.76
Price to Tangible Book Value (P/TBV)	2.21	3.23	2.69	2.81	2.27	2.41	2.09	2.38	2.75	2.34	2.66
Price to Revenue (P/Rev)	2.17	2.79	2.41	2.87	2.91	3.31	3.09	3.10	3.42	3.03	3.07
Price to Earnings (P/E)	2.77	4.32	3.29	3.57	16.95	5.72	5.31	7.04	18.70	46.43	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	36.15%	23.14%	30.40%	27.98%	5.90%	17.48%	18.82%	14.20%	5.35%	2.15%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.41	1.85	1.50	1.64	1.46	1.94	1.75	1.98	2.54	2.16	2.53
Enterprise Value to Revenue (EV/Rev)	1.50	2.33	1.92	2.44	2.37	2.32	1.94	2.17	2.52	2.03	2.19
Enterprise Value to EBITDA (EV/EBITDA)	0.97	2.28	1.81	2.18	5.41	3.06	2.92	3.59	7.33	8.83	17.44
Enterprise Value to EBIT (EV/EBIT)	1.01	2.43	1.96	2.40	7.50	3.65	3.63	4.54	11.21	18.00	185.64
Enterprise Value to NOPAT (EV/NOPAT)	1.23	3.13	2.52	3.21	9.54	3.84	3.57	4.66	12.24	26.78	19.55
Enterprise Value to Operating Cash Flow (EV/OCF)	1.92	3.82	4.73	8.01	5.90	5.10	3.96	4.55	5.45	3.86	4.04
Enterprise Value to Free Cash Flow (EV/FCFF)	1.85	11.20	3.67	5.92	0.00	3.08	2.60	3.20	4.55	11.97	12.26
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.84	0.96	0.79	0.80	0.71	0.66	0.63	0.67	0.67	0.65	0.69
Long-Term Debt to Equity	0.69	0.79	0.79	0.80	0.71	0.66	0.63	0.67	0.38	0.37	0.40
Financial Leverage	-0.44	-0.40	-0.34	-0.32	-0.32	-0.37	-0.41	-0.35	-0.37	-0.48	-0.51
Leverage Ratio	1.95	1.98	2.01	2.01	1.98	1.99	1.89	1.92	1.87	1.86	1.87
Compound Leverage Factor	1.93	2.96	1.96	1.76	1.98	1.96	7.61	2.04	1.79	1.94	2.90
Debt to Total Capital	45.70%	48.85%	44.20%	44.51%	41.53%	39.80%	38.83%	40.19%	40.11%	39.35%	40.96%
Short-Term Debt to Total Capital	8.14%	8.70%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	17.18%	16.85%	17.54%
Long-Term Debt to Total Capital	37.56%	40.16%	44.20%	44.51%	41.53%	39.80%	38.83%	40.19%	22.93%	22.49%	23.42%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	54.30%	51.15%	55.80%	55.49%	58.47%	60.20%	61.17%	59.81%	59.89%	60.65%	59.04%
Debt to EBITDA	0.94	1.60	1.32	1.37	3.50	1.90	2.16	2.23	3.70	5.44	9.69
Net Debt to EBITDA	-0.44	-0.45	-0.46	-0.39	-1.23	-1.31	-1.74	-1.53	-2.65	-4.35	-7.07
Long-Term Debt to EBITDA	0.77	1.31	1.32	1.37	3.50	1.90	2.16	2.23	2.11	3.11	5.54
Debt to NOPAT	1.18	2.20	1.83	2.02	6.17	2.38	2.64	2.90	6.18	16.49	10.85
Net Debt to NOPAT	-0.55	-0.62	-0.64	-0.57	-2.17	-1.64	-2.13	-1.99	-4.42	-13.17	-7.93
Long-Term Debt to NOPAT	0.97	1.81	1.83	2.02	6.17	2.38	2.64	2.90	3.53	9.43	6.21
Altman Z-Score	1.83	1.05	1.28	1.26	1.56	1.77	1.58	1.57	1.74	1.70	1.63
Noncontrolling Interest Sharing Ratio	7.85%	10.19%	14.87%	15.81%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.77	3.29	7.77	8.21	8.43	9.03	10.42	12.70	1.79	2.35	2.48
Quick Ratio	2.28	2.63	5.76	6.45	6.85	7.28	8.51	11.03	1.57	2.11	2.24
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	79	-205	-39	-99	8.46	110	84	45	124	53	54
Operating Cash Flow to CapEx	142,636.36%	26,173.53%	77,830.30%	0.00%	19,357.71%	22,023.84%	0.00%	0.00%	18,031.85%	0.00%	0.00%
Free Cash Flow to Firm to Interest Expense	15.41	-8.32	-8.83	-22.67	1.92	18.44	14.27	7.72	21.38	11.17	11.37
Operating Cash Flow to Interest Expense	3.08	0.36	5.80	8.71	10.00	5.59	6.33	7.54	8.38	12.47	10.32
Operating Cash Flow Less CapEx to Interest Expense	3.08	0.36	5.79	8.71	9.94	5.56	6.35	7.54	8.34	12.47	10.32
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.34	0.31	0.28	0.26	0.23	0.25	0.26	0.28	0.29	0.28	0.29
Accounts Receivable Turnover	4.30	0.00	5.83	4.58	6.99	26.03	21.03	15.72	17.08	20.59	24.01
Inventory Turnover	0.00	0.00	0.00	0.00	0.71	0.88	1.14	1.02	1.14	0.98	0.87
Fixed Asset Turnover	4,146.84	3,641.09	1,712.41	1,723.58	1,104.28	950.88	1,236.47	1,124.14	779.55	719.58	916.59
Accounts Payable Turnover	1.89	9.30	6.24	7.43	10.44	8.83	14.57	12.90	10.70	8.27	12.34
Days Sales Outstanding (DSO)	84.90	0.00	62.63	79.77	52.22	14.02	17.35	23.22	21.37	17.73	15.20
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	512.74	413.60	319.78	356.46	320.51	371.31	417.41
Days Payable Outstanding (DPO)	193.11	39.24	58.52	49.12	34.95	41.33	25.05	28.30	34.10	44.13	29.57
Cash Conversion Cycle (CCC)	-108.21	-39.24	4.11	30.65	530.01	386.29	312.09	351.38	307.78	344.92	403.04
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	397	416	407	433	472	370	344	363	349	336	320
Invested Capital Turnover	1.17	1.01	0.86	0.76	0.67	0.79	0.83	0.83	0.86	1.02	1.11
Increase / (Decrease) in Invested Capital	153	177	76	101	75	-46	-63	-70	-123	-34	-25
Enterprise Value (EV)	559	771	611	708	689	720	604	718	888	728	808
Market Capitalization	809	925	766	834	846	1,028	964	1,024	1,208	1,086	1,136
Book Value per Share	$9.20	$8.11	$8.28	$8.47	$9.64	$10.53	$11.14	$10.66	$10.69	$11.04	$10.32
Tangible Book Value per Share	$5.26	$4.10	$4.21	$4.53	$5.73	$6.66	$7.31	$6.89	$7.03	$7.43	$6.81
Total Capital	1,181	1,106	1,006	1,000	1,073	1,121	1,150	1,113	1,116	1,140	1,096
Total Debt	540	540	445	445	446	446	447	447	448	448	449
Total Long-Term Debt	444	444	445	445	446	446	447	447	256	256	257
Net Debt	-250	-154	-155	-126	-157	-308	-360	-306	-321	-358	-328
Capital Expenditures (CapEx)	0.01	0.03	0.03	0.00	0.23	0.15	-0.10	0.00	0.27	-0.00	0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)	86	114	114	111	89	113	103	113	108	98	93
Debt-free Net Working Capital (DFNWC)	387	405	258	284	269	306	281	330	369	510	539
Net Working Capital (NWC)	291	309	258	284	269	306	281	330	177	318	347
Net Nonoperating Expense (NNE)	2.35	40	2.04	0.60	1.27	1.86	-16	9.50	0.22	-0.94	76
Net Nonoperating Obligations (NNO)	-245	-149	-154	-122	-156	-305	-359	-303	-320	-355	-327
Total Depreciation and Amortization (D&A)	5.43	8.12	7.81	8.94	11	11	10	10	11	11	11
Debt-free, Cash-free Net Working Capital to Revenue	22.98%	34.31%	35.97%	38.26%	30.58%	36.26%	33.09%	34.21%	30.64%	27.25%	25.04%
Debt-free Net Working Capital to Revenue	103.65%	122.15%	81.32%	97.84%	92.56%	98.59%	90.33%	99.87%	104.53%	142.25%	145.87%
Net Working Capital to Revenue	77.89%	93.12%	81.32%	97.84%	92.56%	98.59%	90.33%	99.87%	50.14%	88.71%	93.90%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$3.81	($0.98)	$0.51	$0.02	$1.26	$0.96	$0.58	($0.55)	$0.02	$0.32	($0.74)
Adjusted Weighted Average Basic Shares Outstanding	69.73M	69.64M	67.79M	65.34M	64.95M	65.44M	63.19M	62.53M	62.57M	62.73M	62.71M
Adjusted Diluted Earnings per Share	$2.80	($0.68)	$0.42	$0.02	$0.98	$0.78	$0.46	($0.55)	$0.02	$0.43	($0.74)
Adjusted Weighted Average Diluted Shares Outstanding	95.83M	95.25M	89.79M	65.49M	86.16M	86.88M	84.53M	62.53M	62.95M	74.19M	62.71M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	69.78M	68.13M	65.50M	65.10M	64.09M	63.23M	62.44M	62.56M	62.60M	62.68M	62.78M
Normalized Net Operating Profit after Tax (NOPAT)	232	-28	37	5.97	83	44	21	-25	5.65	19	29
Normalized NOPAT Margin	344.49%	-43.15%	48.32%	7.37%	123.87%	51.41%	26.96%	-25.21%	6.31%	21.12%	32.72%
Pre Tax Income Margin	425.87%	-98.31%	53.87%	7.17%	127.79%	71.30%	58.23%	-39.32%	7.65%	26.90%	-43.54%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	56.79	-1.75	9.53	1.51	19.62	10.48	1.92	-6.37	1.23	4.99	-5.28
NOPAT to Interest Expense	45.47	-1.15	8.34	0.43	18.95	10.65	3.57	-4.34	0.25	4.08	6.16
EBIT Less CapEx to Interest Expense	56.78	-1.75	9.53	1.51	19.56	10.45	1.94	-6.37	1.19	4.99	-5.28
NOPAT Less CapEx to Interest Expense	45.46	-1.15	8.33	0.43	18.90	10.62	3.59	-4.34	0.20	4.08	6.16
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	24.81%	31.69%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	24.81%	35.55%	22.66%	29.68%	139.53%	42.14%	24.57%	27.84%	45.54%	63.17%	-8.72%

Key Financial Trends

Innoviva’s recent quarterly results show robust top-line growth, expanding margins and strong liquidity, but also a sharp swing to a net loss and reduced free cash flow in Q1 2025 compared with the prior year.

Revenue grew 14.4% year-over-year to $88.6 M in Q1 2025.
Operating income margin expanded to 46.7% in Q1 2025 from 33.3% a year earlier.
Gross margin improved to 82.7% in Q1 2025 vs. 77.5% in Q1 2024.
Cash & equivalents rose to $319.1 M in Q1 2025, up from $178.4 M a year ago.
Return on invested capital (ROIC) jumped to 36.4% in Q1 2025 from 26.5%.
Net debt remains negative at –$327.8 M in Q1 2025, compared with –$360.0 M in Q1 2024.
Enterprise value to EBITDA surged to 17.4× in Q1 2025 from 2.9×, reflecting earnings volatility.
Q1 2025 reported a net loss of $46.6 M (EPS –$0.74) vs. net income of $36.5 M (EPS $0.58) a year earlier.
EBITDA swung to a $14.4 M loss in Q1 2025 vs. a $21.7 M gain in Q1 2024.
Free cash flow to firm fell to $53.6 M in Q1 2025 from $83.5 M in Q1 2024.

06/21/25 04:23 PMAI Generated. May Contain Errors.

Frequently Asked Questions About Innoviva's Financials

When does Innoviva's financial year end?

According to the most recent income statement we have on file, Innoviva's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Innoviva's net income changed over the last 10 years?

Innoviva's net income appears to be on an upward trend, with a most recent value of $23.39 million in 2024, falling from -$168.46 million in 2014. The previous period was $179.72 million in 2023. Check out Innoviva's forecast to explore projected trends and price targets.

What is Innoviva's operating income?

Innoviva's total operating income in 2024 was $43.45 million, based on the following breakdown:

Total Gross Profit: $322.11 million
Total Operating Expenses: $278.66 million

How has Innoviva's revenue changed over the last 10 years?

Over the last 10 years, Innoviva's total revenue changed from $8.43 million in 2014 to $358.71 million in 2024, a change of 4,153.7%.

How much debt does Innoviva have?

Innoviva's total liabilities were at $609.90 million at the end of 2024, a 7.3% increase from 2023, and a 18.1% decrease since 2014.

How much cash does Innoviva have?

In the past 10 years, Innoviva's cash and equivalents has ranged from $62.42 million in 2018 to $304.96 million in 2024, and is currently $304.96 million as of their latest financial filing in 2024.

How has Innoviva's book value per share changed over the last 10 years?

Over the last 10 years, Innoviva's book value per share changed from -1.94 in 2014 to 11.04 in 2024, a change of -670.3%.

Related Companies

This page (NASDAQ:INVA) was last updated on 6/21/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Innoviva (INVA) Financials

Key Financial Trends

Frequently Asked Questions About Innoviva's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Innoviva (INVA) Financials

Annual Income Statements for Innoviva

Quarterly Income Statements for Innoviva

Annual Cash Flow Statements for Innoviva

Quarterly Cash Flow Statements for Innoviva

Annual Balance Sheets for Innoviva

Quarterly Balance Sheets for Innoviva

Annual Metrics And Ratios for Innoviva

Quarterly Metrics And Ratios for Innoviva

Key Financial Trends

Frequently Asked Questions About Innoviva's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools